Detalhe da pesquisa
1.
Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus.
Clin Immunol
; 264: 110243, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735509
2.
Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review.
Rheumatology (Oxford)
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552316
3.
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.
Rheumatology (Oxford)
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430004
4.
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.
Eur J Nucl Med Mol Imaging
; 51(5): 1297-1309, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095675
5.
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
J Autoimmun
; : 103147, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114349
6.
Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice.
Rheumatology (Oxford)
; 62(5): 1787-1803, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315063
7.
Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review.
Lupus
; 32(8): 942-951, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229792
8.
Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-ß.
J Immunol
; 207(2): 470-482, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244295
9.
Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network.
J Clin Rheumatol
; 29(1): 29-35, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251449
10.
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome.
Ann Rheum Dis
; 81(7): 979-989, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393271
11.
Obinutuzumab as treatment for ANCA-associated vasculitis.
Rheumatology (Oxford)
; 61(9): 3814-3817, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958343
12.
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
JAMA
; 328(11): 1053-1062, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125471
13.
The diversity of the plasmablast signature across species and experimental conditions: A meta-analysis.
Immunology
; 164(1): 120-134, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041745
14.
B cells in Sjögren's syndrome: from pathophysiology to therapeutic target.
Rheumatology (Oxford)
; 60(6): 2545-2560, 2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770916
15.
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS.
Rheumatology (Oxford)
; 60(2): 675-681, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780813
16.
Comparison of 18- and 22-MHz probes for the ultrasonographic diagnosis of giant cell arteritis.
J Clin Ultrasound
; 49(6): 546-553, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569788
17.
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
Ann Rheum Dis
; 79(9): 1218-1226, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561607
18.
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
J Autoimmun
; 105: 102302, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320177
19.
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort.
Nephrol Dial Transplant
; 34(9): 1508-1517, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30102330
20.
Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
Rheumatology (Oxford)
; 57(4): 666-670, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346621